scispace - formally typeset
M

Ming-Wei Wang

Researcher at Chinese Academy of Sciences

Publications -  251
Citations -  7751

Ming-Wei Wang is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Receptor & G protein-coupled receptor. The author has an hindex of 42, co-authored 226 publications receiving 5645 citations. Previous affiliations of Ming-Wei Wang include University of Cambridge & South China University of Technology.

Papers
More filters
Journal ArticleDOI

Structure of the human glucagon class B G-protein-coupled receptor

TL;DR: The crystal structure of the seven transmembrane helical domain of human GCGR is reported at 3.4 Å resolution, complemented by extensive site-specific mutagenesis, and a hybrid model of glucagon bound to GCGR to understand the molecular recognition of the receptor for its native ligand.
Journal ArticleDOI

Common activation mechanism of class A GPCRs.

TL;DR: By analyzing the conformational changes in 234 structures from 45 class A GPCRs, this work discovered a common GPCR activation pathway comprising of 34 residue pairs and 35 residues, which unifies previous findings into a common activation mechanism and strings together the scattered key motifs.
Journal ArticleDOI

Glucagon-like peptide-1 and its class B G protein-coupled receptors: A long march to therapeutic successes

TL;DR: Small-molecule modulators offer complementary chemical tools to peptide analogs to investigate ligand-directed biased cellular signaling of GLP-1R to provide novel opportunities in the design and development of more efficacious agents to treat metabolic disorders.
Journal ArticleDOI

Insights into the structure of class B GPCRs.

TL;DR: The current review shows how the recently solved crystal structures of the transmembrane domains of the human glucagon receptor and human corticotropin-releasing factor receptor 1 offer more detailed explanations to previous biochemical and pharmacological studies of class B GPCRs, and provides new insights into their interactions with ligands.